[HTML][HTML] Implementing patient-reported outcomes in routine clinical care for diverse and underrepresented patients in the United States

CJ Hyland, R Guo, R Dhawan, MN Kaur…�- Journal of Patient�…, 2022 - Springer
CJ Hyland, R Guo, R Dhawan, MN Kaur, PA Bain, MO Edelen, AL Pusic
Journal of Patient-Reported Outcomes, 2022Springer
Abstract Background Patient-reported outcomes (PROs) are used increasingly in routine
clinical care and inform policies, reimbursements, and quality improvement. Less is known
regarding PRO implementation in routine clinical care for diverse and underrepresented
patient populations. Objective This review aims to identify studies of PRO implementation in
diverse and underrepresented patient populations, elucidate representation of clinical
specialties, assess implementation outcomes, and synthesize patient needs, concerns, and�…
Background
Patient-reported outcomes (PROs) are used increasingly in routine clinical care and inform policies, reimbursements, and quality improvement. Less is known regarding PRO implementation in routine clinical care for diverse and underrepresented patient populations.
Objective
This review aims to identify studies of PRO implementation in diverse and underrepresented patient populations, elucidate representation of clinical specialties, assess implementation outcomes, and synthesize patient needs, concerns, and preferences.
Methods
MEDLINE, Embase, Web of Science, CINAHL, and PsycINFO were searched September 2021 for studies aiming to study PRO implementation in diverse and underrepresented patient populations within the United States. Studies were screened and data extracted by three independent reviewers. Implementation outcomes were assessed according to Proctor et al. taxonomy. A descriptive analysis of data was conducted.
Results
The search yielded 8,687 records, and 28 studies met inclusion criteria. The majority were observational cohort studies (n = 21, 75%) and conducted in primary care (n = 10, 36%). Most studies included majority female (n = 19, 68%) and non-White populations (n = 15, 54%), while fewer reported socioeconomic (n = 11, 39%) or insurance status (n = 9, 32.1%). Most studies assessed implementation outcomes of feasibility (n = 27, 96%) and acceptability (n = 19, 68%); costs (n = 3, 11%), penetration (n = 1, 4%), and sustainability (n = 1, 4%) were infrequently assessed.
Conclusion
PRO implementation in routine clinical care for diverse and underrepresented patient populations is generally feasible and acceptable. Research is lacking in key clinical specialties. Further work is needed to understand how health disparities drive PRO implementation outcomes.
Springer
Showing the best result for this search. See all results